XML 54 R46.htm IDEA: XBRL DOCUMENT
v3.24.3

Stock-Based Compensation (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2024 | Mar. 31, 2024
Compensation Related Costs [Abstract] |  |
Schedule of Restricted Stock Units activity |
Schedule of Restricted Stock Units activity |  |  |  |  |  |  |  |
|  | Restricted Stock Units |
|  | Number of Shares |  |  | Grant Date Fair Value |
Unvested as of April 1, 2024 |  |  | - |  |  |  | - |
Granted |  |  | 3,880,022 |  |  | $ | 5,432 |
Vested |  |  | (3,880,022 | ) |  | $ | 5,432 |
Forfeited / Canceled |  |  | - |  |  |  | - |
Unvested as of June 30, 2024 |  |  | - |  |  |  | - |
Schedule of stock option activity |
Schedule of ESOP stock option activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Shares |  |  | Weighted average exercise price |  |  | Weighted-average remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Options outstanding at April 1, 2024 |  |  | 59,900 |  |  | $ | - |  |  |  | - |  |  | $ | - |
Options granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options canceled, forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options outstanding at June 30, 2024 |  |  | 59,900 |  |  | $ | 0.12 |  |  |  | 4.07 |  |  | $ | 2,303 |
Vested and exercisable at June 30, 2024 |  |  | 59,900 |  |  | $ | 0.12 |  |  |  | 4.07 |  |  | $ | 2,303 |
Schedule of stock option activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Shares |  |  | Weighted average exercise price |  |  | Weighted-average remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Options outstanding at March 31, 2023 |  |  | 59,900 |  |  | $ | - |  |  |  | - |  |  | $ | - |
Options granted |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Options exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options canceled, forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options outstanding at March 31, 2024 |  |  | 59,900 |  |  | $ | 0.12 |  |  |  | 4.32 |  |  | $ | 2,425 |
Vested and exercisable at March 31, 2024 |  |  | 59,900 |  |  | $ | 0.12 |  |  |  | 4.32 |  |  | $ | 2,425 |
Schedule of stock option activity |
Schedule of stock option activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Shares |  |  | Weighted average exercise price |  |  | Weighted-average remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Options outstanding at April 1, 2024 |  |  | 295,565 |  |  | $ | - |  |  |  | - |  |  | $ | - |
Options granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options canceled, forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options outstanding at June 30, 2024 |  |  | 295,565 |  |  | $ | 0.12 |  |  |  | 1.42 |  |  | $ | 11,362 |
Vested and exercisable at June 30, 2024 |  |  | 295,565 |  |  | $ | 0.12 |  |  |  | 1.42 |  |  | $ | 11,362 |
Schedule of stock option activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Shares |  |  | Weighted average exercise price |  |  | Weighted-average remaining contractual term (in years) |  |  | Aggregate intrinsic value |
Options outstanding at March 31, 2023 |  |  | 295,565 |  |  | $ | - |  |  |  | - |  |  | $ | - |
Options granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options canceled, forfeited or expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options outstanding at March 31, 2024 |  |  | 295,565 |  |  | $ | 0.12 |  |  |  | 1.67 |  |  | $ | 11,964 |
Vested and exercisable at March 31, 2024 |  |  | 295,565 |  |  | $ | 0.12 |  |  |  | 1.67 |  |  | $ | 11,964 |
Schedule of weighted average assumptions |
Schedule of weighted average assumptions |  |  |  |
|  | 2022 Grants |
Expected term |  |  | 3.5 years |
Expected volatility |  |  | 40.80 | %
Risk free interest rate |  |  | 3.01 | %
Annual dividend yield |  |  | 0.00 | %
Schedule of weighted average assumptions |  |  |  |
|  | 2022 Grants |
Expected term |  |  | 3.5 years |
Expected volatility |  |  | 40.80 | %
Risk free interest rate |  |  | 3.01 | %
Annual dividend yield |  |  | 0.00 | %

X
- References No definition available. + Details
Name: | aert_ScheduleOfShareBasedCompensationStocksOptionsActivityTableTextBlock
Namespace Prefix: | aert_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CompensationRelatedCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration